This article was originally published in The Rose Sheet
Second quarter sales growth of consumer businesses, which include Consumer Health Care division housing products such as Listerine and Lubriderm, and Shaving Products division, which includes Schick, has been "slower than anticipated," firm tells analysts July 17. Consumer Health Care sales increased 1.7% to $608 mil., while shaving sales decreased 10% to $179 mil. Synergies resulting from acquisition of Warner-Lambert in June 2000 "continue to be larger and to come sooner than originally planned," firm says; Pfizer now expects full-year 2001 merger-related savings of about $1.3 bil., versus prior estimate of $1.2 bil. For 2002, firm anticipates at least $1.6 bil. in merger-related savings, largely from work force cuts, increased purchasing power and reduction of operating expenses. Consolidated second quarter sales up 10% to $7.69 bil., driven by strong Rx drug sales
You may also be interested in...
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
Weekly Trademark Review